The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload

Sverdlov, A.L., Ngo, D. T. M., Nightingale, A. K., Rajendran, S., Mishra, K., Heresztyn, T., Ritchie, R. H., Marwick, T. H., Frenneaux, Michael and Horowitz, J. D. (2011) The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload. Nitric Oxide, 25 (1). pp. 41-46. ISSN 1089-8603

Full text not available from this repository.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Depositing User:	Pure Connector
Date Deposited:	27 Feb 2015 13:12
Last Modified:	15 Oct 2025 10:33
URI:	https://ueaeprints.uea.ac.uk/id/eprint/52301
DOI:	10.1016/j.niox.2011.04.009

Actions (login required)

View Item